1
|
Centers for Disease Control and Prevention
(CDC): Prevalence of chronic kidney disease and associated risk
factors-United States, 1999-2004 MMWR. MMWR Morb Mortal Wkly Rep.
56:161–165. 2007.
|
2
|
Schardong J, Marcolino MAZ and Plentz RDM:
Muscle atrophy in chronic kidney disease. Adv Exp Med Biol.
1088:393–412. 2018. View Article : Google Scholar : PubMed/NCBI
|
3
|
Thome T, Salyers ZR, Kumar RA, Hahn D,
Berru FN, Ferreira LF, Scali ST and Ryan TE: Uremic metabolites
impair skeletal muscle mitochondrial energetics through disruption
of the electron transport system and matrix dehydrogenase activity.
Am J Physiol Cell Physiol. 317:C701–C713. 2019. View Article : Google Scholar : PubMed/NCBI
|
4
|
Garg AX, Blake PG, Clark WF, Clase CM,
Haynes RB and Moist LM: Association between renal insufficiency and
malnutrition in older adults: Results from the NHANES III. Kidney
Int. 60:1867–1874. 2001. View Article : Google Scholar : PubMed/NCBI
|
5
|
Fouque D, Kalantar-Zadeh K, Kopple J, Cano
N, Chauveau P, Cuppari L, Franch H, Guarnieri G, Ikizler TA, Kaysen
G, et al: A proposed nomenclature and diagnostic criteria for
protein-energy wasting in acute and chronic kidney disease. Kidney
Int. 73:391–398. 2008. View Article : Google Scholar
|
6
|
Carrero JJ, Stenvinkel P, Cuppari L,
Ikizler TA, Kalantar-Zadeh K, Kaysen G, Mitch WE, Price SR, Wanner
C, Wang AY, et al: Etiology of the protein-energy wasting syndrome
in chronic kidney disease: A consensus statement from the
International Society of Renal Nutrition and Metabolism (ISRNM). J
Ren Nutr. 23:77–90. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Kovesdy CP, Kopple JD and Kalantar-Zadeh
K: Management of protein-energy wasting in non-dialysis-dependent
chronic kidney disease: Reconciling low protein intake with
nutritional therapy. Am J Clin Nutr. 97:1163–1177. 2013. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kanazawa Y, Nakao T, Murai S, Okada T and
Matsumoto H: Diagnosis and prevalence of protein-energy wasting and
its association with mortality in Japanese haemodialysis patients.
Nephrology (Carlton). 22:541–547. 2017. View Article : Google Scholar
|
9
|
Zhang YY, Gu LJ, Huang J, Cai MC, Yu HL,
Zhang W, Bao JF and Yuan WJ: CKD autophagy activation and skeletal
muscle atrophy-a preliminary study of mitophagy and inflammation.
Eur J Clin Nutr. 73:950–960. 2019. View Article : Google Scholar : PubMed/NCBI
|
10
|
Kobayashi S: Choose delicately and reuse
adequately: The newly revealed process of autophagy. Biol Pharm
Bull. 38:1098–1103. 2015. View Article : Google Scholar : PubMed/NCBI
|
11
|
Klionsky DJ: Autophagy revisited: A
conversation with Christian de Duve. Autophagy. 4:740–743. 2008.
View Article : Google Scholar : PubMed/NCBI
|
12
|
Mizushima N and Komatsu M: Autophagy:
Renovation of cells and tissues. Cell. 147:728–741. 2011.
View Article : Google Scholar : PubMed/NCBI
|
13
|
Demarchi F, Bertoli C, Copetti T,
Eskelinen EL and Schneider C: Calpain as a novel regulator of
autophagosome formation. Autophagy. 3:235–237. 2007. View Article : Google Scholar : PubMed/NCBI
|
14
|
Dear N, Matena K, Vingron M and Boehm T: A
new subfamily of vertebrate calpains lacking a calmodulin-like
domain: Implications for calpain regulation and evolution.
Genomics. 45:175–184. 1997. View Article : Google Scholar : PubMed/NCBI
|
15
|
Tonami K, Kurihara Y, Aburatani H,
Uchijima Y, Asano T and Kurihara H: Calpain 6 is involved in
microtubule stabilization and cytoskeletal organization. Mol Cell
Biol. 27:2548–2561. 2007. View Article : Google Scholar : PubMed/NCBI
|
16
|
Tonami K, Hata S, Ojima K, Ono Y, Kurihara
Y, Amano T, Sato T, Kawamura Y, Kurihara H and Sorimachi H:
Calpain-6 deficiency promotes skeletal muscle development and
regeneration. PLoS Genet. 9:e10036682013. View Article : Google Scholar : PubMed/NCBI
|
17
|
Guttula SV, Rao AA, Sridhar GR,
Chakravarthy MS, Nageshwararo K and Rao P: Cluster analysis and
phylogenetic relationship in biomarker identification of type 2
diabetes and nephropathy. Int J Diabetes Dev Ctries. 30:52–56.
2010. View Article : Google Scholar : PubMed/NCBI
|
18
|
Ko YA, Mohtat D, Suzuki M, Park AS,
Izquierdo MC, Han SY, Kang HM, Si H, Hostetter T, Pullman JM, et
al: Cytosine methylation changes in enhancer regions of core
pro-fibrotic genes characterize kidney fibrosis development. Genome
Biol. 14:R1082013. View Article : Google Scholar : PubMed/NCBI
|
19
|
Andrique C, Morardet L, Linares LK, Cissé
MY, Merle C, Chibon F, Provot S, Haÿ E, Ea HK, Cohen-Solal M and
Modrowski D: Calpain-6 controls the fate of sarcoma stem cells by
promoting autophagy and preventing senescence. JCI insight.
3:e1212252018. View Article : Google Scholar :
|
20
|
Corona Velazquez AF and Jackson WT: So
many roads: The multifaceted regulation of autophagy induction. Mol
Cell Biol. 38:e00303–18. 2018. View Article : Google Scholar : PubMed/NCBI
|
21
|
Zhang C, Yang L, Geng YD, An FL, Xia YZ,
Guo C, Luo JG, Zhang LY, Guo QL and Kong LY: Icariside II, a
natural mTOR inhibitor, disrupts aberrant energy homeostasis via
suppressing mTORC1-4E-BP1 axis in sarcoma cells. Oncotarget.
7:27819–27837. 2016. View Article : Google Scholar : PubMed/NCBI
|
22
|
Morita M, Gravel SP, Hulea L, Larsson O,
Pollak M, St-Pierre J and Topisirovic I: mTOR coordinates protein
synthesis, mitochondrial activity and proliferation. Cell Cycle.
14:473–480. 2015. View Article : Google Scholar : PubMed/NCBI
|
23
|
Francipane MG and Lagasse E: mTOR pathway
in colorectal cancer: An update. Oncotarget. 5:49–66. 2014.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Xu J, Wu Y, Lu G, Xie S, Ma Z, Chen Z,
Shen HM and Xia D: Importance of ROS-mediated autophagy in
determining apoptotic cell death induced by physapubescin B. Redox
Biol. 12:198–207. 2017. View Article : Google Scholar : PubMed/NCBI
|
25
|
Wullschleger S, Loewith R and Hall MN: TOR
signaling in growth and metabolism. Cell. 124:471–484. 2006.
View Article : Google Scholar : PubMed/NCBI
|
26
|
Hands SL, Proud CG and Wyttenbach A:
mTOR's role in ageing: Protein synthesis or autophagy? Aging.
1:586–597. 2009. View Article : Google Scholar
|
27
|
Liu Y, Mei C, Sun L, Li X, Liu M, Wang L,
Li Z, Yin P, Zhao C, Shi Y, et al: The PI3K-Akt pathway regulates
calpain 6 expression, proliferation, and apoptosis. Cell Signal.
23:827–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
28
|
Szeto CC, Kwan BC, Chow KM, Lai KB, Chung
KY, Leung CB and Li PK: Endotoxemia is related to systemic
inflammation and atherosclerosis in peritoneal dialysis patients.
Clin J Am Soc Nephrol. 3:431–436. 2008. View Article : Google Scholar : PubMed/NCBI
|
29
|
McIntyre CW, Harrison LE, Eldehni MT,
Jefferies HJ, Szeto CC, John SG, Sigrist MK, Burton JO, Hothi D,
Korsheed S, et al: Circulating endotoxemia: A novel factor in
systemic inflammation and cardiovascular disease in chronic kidney
disease. Clin J Am Soc Nephrol. 6:133–141. 2011. View Article : Google Scholar :
|
30
|
Thomas SS, Dong Y, Zhang L and Mitch WE:
Signal regulatory protein-alpha interacts with the insulin receptor
contributing to muscle wasting in chronic kidney disease. Kidney
Int. 84:308–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
31
|
Wang DT, Lu L, Shi Y, Geng ZB, Yin Y, Wang
M and Wei LB: Supplementation of ketoacids contributes to the
up-regulation of the Wnt7a/Akt/p70S6K pathway and the
down-regulation of apoptotic and ubiquitin-proteasome systems in
the muscle of 5/6 nephrectomised rats. Br J Nutr. 111:1536–1548.
2014. View Article : Google Scholar : PubMed/NCBI
|
32
|
Bigelman E, Cohen L, Aharon-Hananel G,
Levy R, Rozenbaum Z, Saada A, Keren G and Entin-Meer M:
Pathological presentation of cardiac mitochondria in a rat model
for chronic kidney disease. PLoS One. 13:e01981962018. View Article : Google Scholar : PubMed/NCBI
|
33
|
Rempel LCT, Faustino VD, Foresto-Neto O,
Fanelli C, Arias SCA, Moreira GCDS, Nascimento TF, Ávila VF,
Malheiros DMAC, Câmara NOS, et al: Chronic exposure to hypoxia
attenuates renal injury and innate immunity activation in the
remnant kidney model. Am J Physiol Renal Physiol. 317:F1285–F1292.
2019. View Article : Google Scholar : PubMed/NCBI
|
34
|
Close B, Banister K, Baumans V, Bernoth
EM, Bromage N, Bunyan J, Erhardt W, Flecknell P, Gregory N,
Hackbarth H, et al: Recommendations for euthanasia of experimental
animals: Part 1. DGXI of the European Commission. Lab Anim.
30:293–316. 1996. View Article : Google Scholar : PubMed/NCBI
|
35
|
Wu Y, Zhao W, Zhao J, Zhang Y, Qin W, Pan
J, Bauman WA, Blitzer RD and Cardozo C: REDD1 is a major target of
testosterone action in preventing dexamethasone-induced muscle
loss. Endocrinology. 151:1050–1059. 2010. View Article : Google Scholar :
|
36
|
Qin W, Pan J, Wu Y, Bauman WA and Cardozo
C: Anabolic steroids activate calcineurin-NFAT signaling and
thereby increase myotube size and reduce denervation atrophy. Mol
Cell Endocrinol. 399:336–345. 2015. View Article : Google Scholar
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar
|
38
|
Xu B, Bai B, Sha S, Yu P, An Y, Wang S,
Kong X, Liu C, Wei N, Feng Q and Zhao Q: Interleukin-1β induces
autophagy by affecting calcium homeostasis and trypsinogen
activation in pancreatic acinar cells. Int J Clin Exp Pathol.
7:3620–3631. 2014.
|
39
|
Kimura S, Noda T and Yoshimori T:
Dissection of the autophagosome maturation process by a novel
reporter protein, tandem fluorescent-tagged LC3. Autophagy.
3:452–460. 2007. View Article : Google Scholar : PubMed/NCBI
|
40
|
Masiero E, Agatea L, Mammucari C, Blaauw
B, Loro E, Komatsu M, Metzger D, Reggiani C, Schiaffino S and
Sandri M: Autophagy is required to maintain muscle mass. Cell
Metabol. 10:507–515. 2009. View Article : Google Scholar
|
41
|
Zhang YY, Huang J, Yang M, Gu LJ, Ji JY,
Wang LJ and Yuan WJ: Effect of a low-protein diet supplemented with
keto-acids on autophagy and inflammation in 5/6 nephrectomized
rats. Biosci Rep. 35:e002632015. View Article : Google Scholar : PubMed/NCBI
|
42
|
Sancak Y, Bar-Peled L, Zoncu R, Markhard
AL, Nada S and Sabatini DM: Ragulator-Rag complex targets mTORC1 to
the lysosomal surface and is necessary for its activation by amino
acids. Cell. 141:290–303. 2010. View Article : Google Scholar : PubMed/NCBI
|
43
|
Du J, Mitch WE, Wang X and Price SR:
Glucocorticoids induce proteasome C3 subunit expression in L6
muscle cells by opposing the suppression of its transcription by
NF-kappa B. J Biol Chem. 275:19661–19666. 2000. View Article : Google Scholar : PubMed/NCBI
|
44
|
Cai D, Yuan M, Frantz DF, Melendez PA,
Hansen L, Lee J and Shoelson SE: Local and systemic insulin
resistance resulting from hepatic activation of IKK-beta and
NF-kappaB. Nat Med. 11:183–190. 2005. View
Article : Google Scholar : PubMed/NCBI
|
45
|
Zhang L, Rajan V, Lin E, Hu Z, Han HQ,
Zhou X, Song Y, Min H, Wang X, Du J and Mitch WE: Pharmacological
inhibition of myostatin suppresses systemic inflammation and muscle
atrophy in mice with chronic kidney disease. FASEB J. 25:1653–1663.
2011. View Article : Google Scholar : PubMed/NCBI
|
46
|
Zhao J, Brault JJ, Schild A, Cao P, Sandri
M, Schiaffino S, Lecker SH and Goldberg AL: FoxO3 coordinately
activates protein degradation by the autophagic/lysosomal and
proteasomal pathways in atrophying muscle cells. Cell Metabol.
6:472–483. 2007. View Article : Google Scholar
|
47
|
Yamamoto D, Maki T, Herningtyas EH,
Ikeshita N, Shibahara H, Sugiyama Y, Nakanishi S, Iida K, Iguchi G,
Takahashi Y, et al: Branched-chain amino acids protect against
dexamethasone-induced soleus muscle atrophy in rats. Muscle Nerve.
41:819–827. 2010. View Article : Google Scholar : PubMed/NCBI
|
48
|
Bailey JL, Zheng B, Hu Z, Price SR and
Mitch WE: Chronic kidney disease causes defects in signaling
through the insulin receptor substrate/phosphatidylinositol
3-kinase/Akt pathway: Implications for muscle atrophy. J Am Soc
Nephrol. 17:1388–1394. 2006. View Article : Google Scholar : PubMed/NCBI
|
49
|
Turner NJ and Badylak SF: Regeneration of
skeletal muscle. Cell Tissue Res. 347:759–774. 2012. View Article : Google Scholar
|
50
|
Dear TN and Boehm T: Diverse mRNA
expression patterns of the mouse calpain genes Capn5, Capn6 and
Capn11 during development. Mech Dev. 89:201–209. 1999. View Article : Google Scholar : PubMed/NCBI
|